StockData
Aktis Oncology, Inc. logo

Aktis Oncology, Inc. (AKTS) stock

AKTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$16.10−0.21 (-1.29%)

Close on Nov 18, 2026Market cap $895.47MP/E –Yield –

Aktis Oncology price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Aktis Oncology's price to book ratio was 1.9× on Nov 11, 2026.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.9×–

More Aktis Oncology figures

See a number that looks wrong?